PTJ
ALNY icon

Paul Tudor Jones’s Alnylam Pharmaceuticals ALNY Stock Holding History

Paul Tudor Jones’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,386
Closed -$890K – 2971
2024
Q3 		$931K Sell
3,386
-57,007
-94% -$14.8M ﹤0.01% 1666
2024
Q2 		$14.7M Buy
+60,393
New +$9.53M 0.08% 250
2024
Q1 		– Sell
-64,096
Closed -$12.3M – 2176
2023
Q4 		$12.3M Buy
64,096
+4,092
+7% +$697K 0.1% 274
2023
Q3 		$10.6M Buy
60,004
+51,377
+596% +$9.8M 0.11% 214
2023
Q2 		$1.64M Buy
+8,627
New +$1.71M 0.02% 1010
2022
Q4 		– Sell
-29,859
Closed -$5.98M – 2330
2022
Q3 		$5.98M Buy
29,859
+28,014
+1,518% +$5.34M 0.13% 178
2022
Q2 		$269K Buy
+1,845
New +$262K 0.01% 1633
2022
Q1 		– Sell
-24,057
Closed -$4.08M – 1960
2021
Q4 		$4.08M Sell
24,057
-4,196
-15% -$780K 0.07% 335
2021
Q3 		$5.33M Buy
+28,253
New +$5.3M 0.09% 246
2021
Q2 		– Sell
-19,022
Closed -$2.69M – 1579
2021
Q1 		$2.69M Buy
+19,022
New +$2.86M 0.05% 393
2020
Q2 		– Sell
-3,667
Closed -$399K – 1152
2020
Q1 		$399K Sell
3,667
-2,077
-36% -$240K 0.04% 581
2019
Q4 		$662K Buy
+5,744
New +$573K 0.03% 637
2019
Q3 		– Sell
-29,989
Closed -$2.18M – 1065
2019
Q2 		$2.18M Buy
+29,989
New +$2.3M 0.06% 299
2015
Q1 		– Sell
-3,540
Closed -$343K – 1431
2014
Q4 		$343K Buy
+3,540
New +$328K 0.01% 964

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paul Tudor Jones's ALNY Position: Q4 2024 in Review

Paul Tudor Jones sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2024, closing a stake of 3,386 shares — an estimated $890K sold.

Paul Tudor Jones first reported a position in ALNY in Q4 2014 and held it in 14 quarters. The position peaked at $14.7M in Q2 2024. 594 funds tracked by Wall St. Rank hold ALNY as of Q4 2024.

  • Paul Tudor Jones reported no remaining Alnylam Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 3,386 Alnylam Pharmaceuticals shares in Q4 2024, an estimated $890K.
  • Paul Tudor Jones first reported a position in Alnylam Pharmaceuticals in Q4 2014 and held it in 14 quarters.
  • Paul Tudor Jones's Alnylam Pharmaceuticals position peaked at $14.7M in Q2 2024.
  • 594 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.